Limited information exists on adults ≥50 years receiving HIV care in sub-Saharan Africa.Using routinely-collected longitudinal patient-level data among 391,111 adults ≥15 years enrolling in HIV care from January 2005–December 2010 and 184,689 initiating ART, we compared characteristics and outcomes between older (≥50 years) and younger adults at 199 clinics in Kenya, Mozambique, Rwanda, and Tanzania. We calculated proportions over time of newly enrolled and active adults receiving HIV care and initiating ART who were ≥50 years; cumulative incidence of loss to follow-up (LTF) and recorded death one year after enrollment and ART initiation, and CD4+ response following ART initiation. lower than for adults 25–39 years of age (95% CI: 17.1–24.1...
BACKGROUND: There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are...
Background: Reporting mortality and lost to follow-up (LTFU) by age is essential as older HIV-positi...
Background: Antiretroviral therapy (ART) has decreased HIV-related morbidity and mortality and incre...
<div><p>Background</p><p>Limited information exists on adults ≥50 years receiving HIV care in sub-Sa...
Limited information exists on adults ≥50 years receiving HIV care in sub-Saharan Africa. Using routi...
Background: Limited information exists on adults $50 years receiving HIV care in sub-Saharan Africa....
Although scale-up of antiretroviral therapy (ART) since 2005 has contributed to a decline of about 3...
Introduction: HIV-infected adults aged over 50 years in South Africa are increasing. This study expl...
OBJECTIVE:Clinical and immunological data about HIV in older adults from low and middle income count...
There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positiv...
OBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income coun...
To estimate patients enrolling on antiretroviral therapy (ART) over time; describe trends in baselin...
There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positiv...
Clinical and immunological data about HIV in older adults from low and middle income countries is sc...
BACKGROUND:The prevalence of HIV infection among older persons is increasing yet older age at initia...
BACKGROUND: There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are...
Background: Reporting mortality and lost to follow-up (LTFU) by age is essential as older HIV-positi...
Background: Antiretroviral therapy (ART) has decreased HIV-related morbidity and mortality and incre...
<div><p>Background</p><p>Limited information exists on adults ≥50 years receiving HIV care in sub-Sa...
Limited information exists on adults ≥50 years receiving HIV care in sub-Saharan Africa. Using routi...
Background: Limited information exists on adults $50 years receiving HIV care in sub-Saharan Africa....
Although scale-up of antiretroviral therapy (ART) since 2005 has contributed to a decline of about 3...
Introduction: HIV-infected adults aged over 50 years in South Africa are increasing. This study expl...
OBJECTIVE:Clinical and immunological data about HIV in older adults from low and middle income count...
There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positiv...
OBJECTIVE: Clinical and immunological data about HIV in older adults from low and middle income coun...
To estimate patients enrolling on antiretroviral therapy (ART) over time; describe trends in baselin...
There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positiv...
Clinical and immunological data about HIV in older adults from low and middle income countries is sc...
BACKGROUND:The prevalence of HIV infection among older persons is increasing yet older age at initia...
BACKGROUND: There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are...
Background: Reporting mortality and lost to follow-up (LTFU) by age is essential as older HIV-positi...
Background: Antiretroviral therapy (ART) has decreased HIV-related morbidity and mortality and incre...